Leslie Shaw to Cost-Benefit Analysis
This is a "connection" page, showing publications Leslie Shaw has written about Cost-Benefit Analysis.
Connection Strength
0.034
-
Shaw LM, Bonner HS, Fields L, Lieberman R. The use of concentration measurements of parent drug and metabolites during clinical trials. Ther Drug Monit. 1993 Dec; 15(6):483-7.
Score: 0.024
-
Hachamovitch R, Shaw L, Berman DS. Methodological considerations in the assessment of noninvasive testing using outcomes research: pitfalls and limitations. Prog Cardiovasc Dis. 2000 Nov-Dec; 43(3):215-30.
Score: 0.010